Pulmozyme 1 MG/ML ampul 2.5ML
Ended Awarded
- Contract number
- SPE2DB25FGW91
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,388
Award facts
- Contract value 100% obligated
- $18,388.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a delivery order valued at $18,388.41 to AmerisourceBergen Drug Corp for the supply of Pulmozyme 1 mg/ml ampules (2.5 ml vials). This firm fixed-price, non-set-aside delivery order was awarded on May 8, 2025, with an ultimate completion date of May 9, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location. This award represents a child delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
The delivery order is funded through the Defense Logistics Agency's Medical Supply Chain, which supports military and veteran healthcare systems across multiple therapeutic domains. AmerisourceBergen Drug Corp maintains an extensive portfolio of federal pharmaceutical contracts with DLA, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The company's competitively awarded contracts demonstrate its capability to fulfill federal medical procurement requirements at various transaction values. This particular award for Pulmozyme, a respiratory therapy medication, aligns with the broader scope of the SPE2DX contract vehicle, which authorizes AmerisourceBergen Drug Corp to supply critical pharmaceutical products globally in support of military healthcare programs and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FGW91?
SPE2DB25FGW91 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 8, 2025.
How much is contract SPE2DB25FGW91 worth?
The government has obligated $18,388 on SPE2DB25FGW91.
Is contract SPE2DB25FGW91 an order under another contract?
Yes. SPE2DB25FGW91 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FGW91 competed?
The extent of competition for SPE2DB25FGW91 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award